3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
58
Carcinoma, Non-Small-Cell Lung
36
Urinary Bladder Neoplasms
33
Neoplasm Metastasis
20
Lung Neoplasms
20
Ovarian Neoplasms
19
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
16
Biliary Tract Neoplasms
15
Neoplasms
14
Nasopharyngeal Carcinoma
14
Triple Negative Breast Neoplasms
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Fallopian Tube Neoplasms
10
Recurrence
9
Non-Muscle Invasive Bladder Neoplasms
9
Gallbladder Neoplasms
9
Bile Duct Neoplasms
7
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Uterine Cervical Neoplasms
5
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Hodgkin Disease
5
Endometrial Neoplasms
5
Melanoma
4
Gastrointestinal Neoplasms
4
Interventions
tislelizumab
1
bintrafusp alfa protein, human
1
Injections
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Metastatic Solid Tumors
×
Gemcitabine
×
90 days
×
Clear all
No trials found.